Ann: Head-to-head IIT with SAR-bisPSMA, page-64

First 64 Last

Share
Profile

Follow
flotsam222

5,523 Posts.

401

19/11/24

17:14

Post #: 76679870
Share

Originally posted by ttppxx: ↑

IS THIS REALLY NECESSARY?

Answer: YES!

PATIENTS: Noone wants to be told they are cancer free, then discover a short while later that the cancer (that was missed) has spread further and is now attacking somewhere else.

DOCTORS: Your patients won't thank you for giving them an inferior test when a better one exists. So, for Louise and co, this is the most natural progression. They have been public about this test that seems to be so much better! Only through research can they access and use this better diagnostic. It's a win win win (patient, doctor, company).

SOCIETY: Most definitely. Delayed treatment costs a lot more due to complications, more extensive therapies, loss of economic activity due to the patient missing work, etc.

CLARITY (the business): If this proves to be the best in class, Clarity's value will sky rocket. Imagine the perfect paring: Diagnose with the best (Cu64), and treat with the best (Cu67). Who would choose to be diagnosed using Cu64 and then get treated with Pluvicto, if the perfect pairing proves to be perfect?
Also remember that the company can use the data in its applications for filing with the various authorities.

Costs? The tendency is for the company to provide some or all product free of charge, while the hospital covers staff costs as normal.

Expand

It's already known to produce better images and find smaller masses than both illucix and pylarify in the older conventional scanners.

So it sure looks like a marketing exercise.

It's other considerations which will determine market performance.

CU6 Price at posting: $6.27 Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Monday's HotCopper trends: DroneShield contract, Vection pilot order | June 30

FCT

FirstWave inks $400K deal with Dominican Republic major telecom

EOS

Two defence stocks, two $60M deals – why EOS shares are going up

AII

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 64 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.50		Change -0.020(0.79%)		Mkt cap ! $803.6M

Open	High	Low	Value	Volume
$2.53	$2.63	$2.42	$5.288M	2.113M

Buyers (Bids)

No.	Vol.	Price($)
4	1829	$2.49

Sellers (Offers)

Price($)	Vol.	No.
$2.51	260	1

View Market Depth

No.	Vol.	Price($)
4	1829	2.490
1	1000	2.480
1	8532	2.470
1	8532	2.460
2	12613	2.450

Price($)	Vol.	No.
2.510	260	1
2.520	50	1
2.530	25792	2
2.540	34399	4
2.550	6449	2

Last trade - 16.10pm 30/06/2025 (20 minute delay)

CU6 (ASX) Chart

Ann: Head-to-head IIT with SAR-bisPSMA, page-64

Monday's HotCopper trends: DroneShield contract, Vection pilot order | June 30

FirstWave inks $400K deal with Dominican Republic major telecom

Two defence stocks, two $60M deals – why EOS shares are going up

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Head-to-head IIT with SAR-bisPSMA, page-64

Top Stories

Monday's HotCopper trends: DroneShield contract, Vection pilot order | June 30

FirstWave inks $400K deal with Dominican Republic major telecom

Two defence stocks, two $60M deals – why EOS shares are going up

Almonty Industries shares EXPLODE! Rheinmetall, Renk, and Hensoldt left in the shadows!

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News